Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-15-067598
Filing Date
2015-11-23
Accepted
2015-11-23 18:03:59
Documents
2
Period of Report
2015-11-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 v425444_form3.html 3  
1 FORM 3 v425444_form3.xml 3 1629
2 EXHIBIT 24 v425444_ex24.htm EX-24 9222
  Complete submission text file 0001144204-15-067598.txt   12302
Mailing Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016 646-440-9310
IMMUNE PHARMACEUTICALS INC (Issuer) CIK: 0001208261 (see all company filings)

EIN.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address
Luchi Monica E. (Reporting) CIK: 0001659113 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36602 | Film No.: 151250704